Brief: Intra-Cellular Therapies Reports First Quarter 2022 Financial Results And Provides Corporate Update

Intra-Cellular Therapies

10/05/2022 12:33

May 10 (Reuters) - Intra-Cellular Therapies Inc  ITCI.O :
    * INTRA-CELLULAR THERAPIES REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q1 REVENUE ROSE 120 PERCENT TO $35 MILLION
    * QTRLY NET LOSS PER COMMON SHARE BASIC & DILUTED $0.78
    * Q1 EARNINGS PER SHARE VIEW $-0.92, REVENUE VIEW $33.7
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX4Z72Dw 
Further company coverage:  ITCI.O 

 ((Reuters.Briefs@thomsonreuters.com;))